Sleep Apnea is highly prevalent in patients with cardiovascular disease. These disordered breathing events are associated with a profile of perturbations that include intermittent hypoxia, oxidative stress, sympathetic activation, and endothelial dysfunction
J-P. Baguet, G. Barone-Rochette, Lévy, E. Vautrin, H. Pierre,O. Ormezzano, J-L. Pépin
Eur Respir J 2010;36: 1323–1329
Authors review of the epidemiological data on the impact of sleep duration and disorders on cardiovascular health suggests the following
Sleep Apnea as cardiovascular comorbidity has been known for over 2 decades. The prevalence of sleep apnea in cardiac patients is estimated to be over 50% and includes Drug-Resistant Hypertension, Coronary Artery Disease, Heart Failure, Diabetes, Atrial Fibrillation and other
Arrhythmias, Sudden Cardiac Death, Stroke and even Depression.
Patients at an outpatient cardiology clinic without known OSA (Obstructive Sleep Apnea) were screened using a questionnaire for signs and symptoms of OSA. Patients with high scores were referred for testing.